Skip to main content
. Author manuscript; available in PMC: 2013 Apr 29.
Published in final edited form as: J Neurochem. 2008 Jul 1;106(1):464–474. doi: 10.1111/j.1471-4159.2008.05398.x

Table 1.

Half-life of PINK1 isoforms

PINK1 isoform Treatment T½ (min) T½ (min) 95% CI Curve fit R2 value
FL Control 27.31 20.50–40.87 0.9171
Δ1 Control 30.18 22.62–45.33 0.9043
Δ2 Control > 120 ND 0.2946
FL MG-132 29.74 19.33–64.38 0.7527
Δ1 MG-132 57.31 37.60–120.5 0.7672
Δ2 MG-132 > 120 ND 0.4486
FL 17-AAG 31.61 20.55–68.43 0.7171
Δ1 17-AAG 24.7 16.48–49.28 0.7863
FL Valino > 120 ND 0.1682
FL Valino + 17-AAG 114.1 79.14–204.2 0.7266

PINK1, PTEN-induced putative kinase 1; FL, full length; 17-AAG, 17- (allylamino)-17-demethoxygeldanamycin; ND, not determined.